Scientific evaluation of community-based Parkinson's disease nurse specialists on patient outcomes and health care costs

Abstract

Objective: To determine the effects of community based nurses specialising in Parkinson's disease on health outcomes and healthcare costs. Design: Two year randomised controlled trial in 438 general practices in nine randomly selected health authority areas of England. Participants: 1859 patients with Parkinson's disease identified by the participating general practices. Main outcome measures: Survival, stand-up test, dot in square test, bone fracture, global health question, PDQ-39, Euroqol, and healthcare costs. Results: After two years 315 (17.3%) patients had died, although mortality did not differ between those who were attended by nurse specialists and those receiving standard care from their general practitioner (hazard ratio for nurse group v control group 0.91, 95% confidence interval 0.73 to 1.13). No significant differences were found between the two groups for the stand-up test (odds ratio 1.15, 0.93 to 1.42) and dot in square score (difference -0.7, -3.25 to 1.84). Scores on the global health question were significantly better in patients attended by nurse specialists than in controls (difference -0.23, -0.4 to -0.06), but no difference was observed in the results of the PDQ-39 or Euroqol questionnaires. Direct costs for patient health care increased by an average of £2658 during the study, although not differentially between groups: the average increase was £266 lower among patients attended by a nurse specialist (-£981 to £449). Conclusions: Nurse specialists in Parkinson's disease had little effect on the clinical condition of patients, but they did improve their patients' sense of wellbeing, with no increase in patients' healthcare costs. © 2005 Blackwell Publishing Ltd.